Disclosure: We may earn a commission if you sign up through some links on this site, at no extra cost to you. We do not accept payment for favorable reviews. Read our full affiliate disclosure.
Maximus at a Glance
- What it is
- The only provider here that will manage a GLP-1 and testosterone together — with the cheapest microdose entry point we have found
- Medication type
- Brand-name and compounded
- Medications offered
- Compounded semaglutide with glycine and B12
- Compounded semaglutide microdose plan
- Brand-name GLP-1s, added June 2026
- Testosterone and enclomiphene, prescribable alongside a GLP-1
- Pricing
- Microdose semaglutide from $79.99/mo; standard $149.99 first month then $249.99/mo — all-in, no membership
- Insurance
- Compounded medication is never covered. Brand-name options added in June 2026 could be covered in principle, though Maximus does not publish an insurance pathway. HSA and FSA cards are accepted.
- Date reviewed
- August 7, 2026
How we scored it
Scores follow the published rubric in our provider comparison methodology.
Medical Disclaimer
We're not doctors, and this review is not medical advice. GLP-1 medications are prescription-only and require evaluation by a licensed healthcare provider. What works for one person may not work for another, and only a clinician who knows your history can determine whether a medication is appropriate for you. See our full medical disclaimer.
What Is Maximus?
Maximus began as a men's testosterone platform and added GLP-1s on top, and that history produces its single best feature: it will manage weight-loss medication and testosterone or enclomiphene under one provider. Our guide to testosterone and GLP-1 weight loss sets out why that matters — obesity suppresses testosterone, weight loss often raises it back, and having one clinician watching both means the retest actually happens rather than two services working blind to each other.
Pricing is all-in, which Maximus states plainly: medication, clinical oversight and shipping in one figure with no membership fee. Its microdose semaglutide plan starts at $79.99/month, which is the cheapest entry point into GLP-1 treatment we have found anywhere. Standard compounded semaglutide is $149.99 for a first month and $249.99/month thereafter — a 67% step-up that the entry price does not signal. Brand-name GLP-1s were added in June 2026 with a $100 first-month discount.
One detail deserves explanation rather than a shrug. Maximus adds glycine and B12 to its semaglutide formulations, describing this as customising the medication. That is the mechanism much of this industry now relies on: because the FDA declared the semaglutide shortage resolved in February 2025, compounding a straight copy is no longer permitted, but a formulation combined with a vitamin can be framed as a patient-specific personalised preparation. It is a legal position rather than a clinical one — there is no evidence that adding glycine or B12 improves weight-loss outcomes, and the FDA has signalled further action in this area.
Coaching is included and is led by psychologists rather than generalist coaches, which is a better standard than most of this market applies. HSA and FSA cards are accepted.
How the Program Works
- Consultation process
- Online intake with clinician review. Clinical oversight is included in the stated price rather than billed as a membership.
- Eligibility
- Clinician-assessed. Maximus is built for men, and does not publish a BMI threshold or a list of states it serves.
- Provider involvement
- Licensed clinicians prescribe and manage, with the notable ability to coordinate a GLP-1 alongside testosterone or enclomiphene. Psychologist-led community coaching is included.
- Lab requirements
- Not published as a universal requirement for the weight-loss protocols, though its testosterone side involves bloodwork.
- Pharmacy fulfillment
- Compounded medication from partner pharmacies, which Maximus does not name. Its semaglutide is formulated with glycine and B12 rather than as a straight copy.
- Shipping frequency
- Monthly, included in the stated all-in price.
- Support services
- Clinical oversight, shipping and psychologist-led community coaching, all inside the medication price with no membership fee.
Maximus Pricing
- Membership fee
- None. Maximus states the price shown is all-in, covering medication, clinical oversight and shipping.
- Medication fee
- Compounded microdose semaglutide from $79.99/month. Standard compounded semaglutide at $149.99 for the first month and $249.99/month ongoing. Brand-name GLP-1s were added in June 2026, each with a $100 first-month discount.
- Cancellation policy
- Not published in detail. Confirm the terms and any notice requirement before subscribing, particularly given the step-up after the first month.
- Refund policy
- Not published. Compounded medication is not returnable once dispensed.
- Insurance
- Compounded medication is never covered. Brand-name options added in June 2026 could be covered in principle, though Maximus does not publish an insurance pathway. HSA and FSA cards are accepted.
- HSA / FSA
- Explicitly accepted for weight-loss treatment.
Pricing details worth knowing
- The microdose plan at $79.99/month is the cheapest GLP-1 entry point in this comparison — genuinely useful if you tolerate standard doses badly or want to start gently.
- The standard plan steps up from $149.99 to $249.99 after month one. Budget the second figure.
- At $249.99 ongoing this is upper-mid — Ondra Health publishes $96/month and Trimi $99/month annually.
- Formulations include glycine and B12. That is a compounding-rules workaround rather than a clinical enhancement; no evidence supports better outcomes from the additions.
- HSA and FSA cards are accepted for weight-loss treatment.
Prices change. Every figure above was taken from Maximus's published pages or the named sources at the bottom of this review, as of August 7, 2026. Telehealth pricing in this market changes frequently, and promotional rates expire. Confirm your actual cost at checkout before enrolling.
Pros and Cons
Pros
- Will manage a GLP-1 alongside testosterone or enclomiphene under one provider — unique in this comparison
- Microdose semaglutide from $79.99/month, the cheapest entry point we have found
- All-in pricing with no membership fee — medication, clinical oversight and shipping in one figure
- Psychologist-led coaching rather than generalist coaching
- HSA and FSA cards accepted
- Brand-name GLP-1s available since June 2026 alongside compounded options
Cons
- Standard plan steps up from $149.99 to $249.99 after the first month
- $249.99 ongoing is roughly 2.5 times the cheapest compounded providers
- Formulations add glycine and B12 as a compounding workaround, with no outcome evidence behind the additions
- Does not name its compounding pharmacy, a medical director, or the states it serves
- No published cancellation or refund terms
- Built for men, so it is not a general-purpose option
Who Maximus May Be Best For
Men who want weight-loss medication and testosterone managed by the same provider rather than two disconnected services
Anyone who tolerates standard GLP-1 doses poorly and wants a genuine microdose route at $79.99/month
People who want coaching with actual clinical training behind it
Limitations
Budget $249.99, not $149.99. The first-month rate is an introduction, and the gap is $1,200 a year.
Understand what the glycine and B12 are for. They are there to make the preparation a personalised formulation rather than a copy — a regulatory position, not a clinical benefit.
If you are considering both a GLP-1 and testosterone, read our testosterone guide first. The sequencing matters, and weight loss alone often raises testosterone without treatment.
Compounded medication carries the regulatory caveats described below, including the FDA proposal published in May 2026.
About Compounded GLP-1s
The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved in February 2025, which ended the window for compounding pharmacies to make large volumes of copies of those drugs (503A pharmacies had until April 22, 2025; 503B outsourcing facilities until May 22, 2025). Many telehealth companies continue to offer compounded GLP-1s prescribed for an individual patient — often as a personalized dose, a microdose, or a formulation combined with a vitamin such as B12 or B6. That practice sits in a contested legal area, and the FDA has continued to act. In a Federal Register notice published on May 1, 2026, the FDA proposed not to include semaglutide, tirzepatide or liraglutide on the 503B bulks list, saying it had not identified sufficient evidence of a clinical need for outsourcing facilities to compound them from bulk substances; the comment period was extended to July 30, 2026. Separately, in February 2026 the FDA issued warning letters to 30 telehealth companies over false or misleading claims about compounded GLP-1s, and it has continued: a further round dated 8 June 2026 — 25 warning letters, posted publicly on 16 June 2026 — reached companies including Medica Weight Loss, FITISH and Roen Health (RoenRx), again over false or misleading claims about compounded semaglutide and tirzepatide that the FDA said made the products misbranded under sections 502(a) and 502(bb) of the FD&C Act. The claims cited included suggesting the products were FDA-approved, implying equivalence to Ozempic, Wegovy, Mounjaro or Zepbound, and asserting the "same active ingredient" or "same results" as the approved drugs. Compounded medications are not FDA-approved, which means they have not gone through the same review as the brand-name products.
None of that is specific to Maximus — it applies to every provider offering compounded medication. We cover the trade-offs in detail in our guide to brand-name versus compounded GLP-1s.
Alternatives to Maximus
Hone Health
The other men's hormone platform with a GLP-1, though its only option is liraglutide
Read review →bmiMD
Also offers a dedicated tirzepatide microdose plan, with a wider format range
Read review →Ondra Health
$96/mo flat at every dose with all five pharmacies named, if hormones are not part of the picture
Read review →vs. CoreAge RX, our top-rated platform
Across the platforms we've reviewed, CoreAge RX remains our highest-rated option for cash-pay patients, with compounded semaglutide from $99/month and tirzepatide from $149/month including free two-day shipping. Whether it beats Maximus for you depends on the things this review has covered — insurance, medication type, and how much support you actually want.
Frequently Asked Questions
How much does Maximus cost?
Microdose semaglutide starts at $79.99/month — the cheapest GLP-1 entry point we have found anywhere. Standard compounded semaglutide is $149.99 for the first month and $249.99/month thereafter. There is no membership fee: Maximus states the price shown is all-in, covering medication, clinical oversight and shipping. Brand-name GLP-1s were added in June 2026 with a $100 first-month discount.
Why does Maximus add glycine and B12 to its semaglutide?
It makes the preparation a personalised formulation rather than a straight copy of an approved drug. Since the FDA declared the semaglutide shortage resolved in February 2025, compounding copies at volume has not been permitted — but combining the molecule with a vitamin lets a provider frame it as patient-specific. Much of this industry now does the same thing with B12 or B6. Be clear about what it is: a regulatory position, not a clinical upgrade. There is no evidence that glycine or B12 improves weight-loss outcomes.
Can Maximus prescribe testosterone and a GLP-1 together?
Yes, and it is the main reason to choose it. Maximus came from men's hormone therapy and will manage a GLP-1 alongside testosterone or enclomiphene under one provider. That matters more than it sounds: obesity suppresses testosterone, substantial weight loss often raises it back, and a single clinician watching both is far more likely to retest before committing you to lifelong therapy than two services that do not know about each other. Our testosterone guide covers the sequencing.
Is the $79.99 microdose plan worth it?
It is a genuine option for a specific group: people who tolerate standard GLP-1 doses badly, and people who want to start gently and titrate up under supervision. It is also the cheapest way into treatment in this comparison. Be realistic about what a lower dose means — the substantial weight-loss figures from clinical trials come from full therapeutic doses of the branded drugs, and a microdose should not be expected to match them.
Who should not use Maximus?
Anyone shopping purely on the ongoing price, since $249.99 is well above the cheapest compounded providers. Anyone wanting a general-purpose service rather than one built around men's health. Separately, GLP-1 medications are not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, if you are pregnant or trying to conceive, or if you have had pancreatitis — and testosterone therapy suppresses fertility, which is covered in our testosterone guide. A licensed clinician who knows your history should decide.
The Verdict
Maximus is a men's health platform that added GLP-1s to an existing testosterone business, which produces a genuine differentiator: it can manage weight-loss medication and testosterone or enclomiphene under one provider rather than two. Microdose semaglutide starts at $79.99/month with no membership fee. The standard plan steps up sharply after month one, and its formulations add glycine and B12 for reasons worth understanding.
Opens Maximus's official site · Verify current pricing there
Compare Every Provider Side by Side
See how Maximus stacks up against every platform we've reviewed on price, medication type, and what's actually included.
How We Researched This Review
We compiled this review on August 7, 2026 from Maximus's own published pages plus independent reporting. We have not signed up for this service ourselves, and we say so rather than implying firsthand testing. Where Maximus does not publish a detail — refund terms, lab requirements, pharmacy partners — we've said that plainly instead of guessing.
Sources
- maximustribe.com/weight-loss and support.maximustribe.com — compounded semaglutide at $149.99 first month and $249.99/month ongoing; microdose semaglutide from $79.99/month with no membership fee; name-brand GLP-1s added 11 June 2026 with a $100 first-month discount; all-in pricing covering medication, clinical oversight and shipping; HSA and FSA cards accepted (checked August 7, 2026)
- maximustribe.com — formulations combining semaglutide with glycine and B12 described as customising the medication; psychologist-led community coaching included; ability to combine a GLP-1 with testosterone or enclomiphene under one provider
- FDA declaration that the semaglutide shortage was resolved in February 2025, which underlies the personalised-formulation approach described above
Affiliate Disclosure: This review may contain affiliate links. If you click a link and sign up, we may receive a commission at no additional cost to you. We do not accept payment for favorable coverage, and commission relationships do not affect our scores. Read our full affiliate disclosure policy.